Skip to main content
Isabella Glitza, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

IsabellaClaudiaGlitzaMD

Oncology Houston, TX

Physician

Dr. Glitza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Glitza's full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2007 - 2010
  • Ruprecht Karl University Faculty of Medicine
    Ruprecht Karl University Faculty of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2011 - 2024
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • PA State Medical License
    PA State Medical License 2007 - 2012
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
  • Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
  • Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Richard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
  • Join now to see all

Press Mentions

  • Stage IV Melanoma Survivor: Immunotherapy Clinical Trial Gave Me My Life Back
    Stage IV Melanoma Survivor: Immunotherapy Clinical Trial Gave Me My Life BackJune 12th, 2019

Hospital Affiliations